Stockhub

Belite Bio, Inc: Revision history

View logs for this page

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

15 August 2022

11 August 2022

27 July 2022

  • curprev 00:1700:17, 27 July 2022‎ Chris talk contribs‎ 887 bytes +887‎ Created page with "Belite Bio, Inc, a clinical-stage biopharmaceutical drug development company, engages in the research and development of novel therapeutics targeting atrophic age-related macular degeneration and autosomal recessive stargardt diseases. Its lead product candidate is LBS-008, an oral once-a-day treatment that can reduce and maintain the delivery of vitamin A to the eye to reduce the accumulation of toxic vitamin A by-products in ocular tissue that is in phase 3 clinical tr..." Tag: Visual edit
Retrieved from ‘https://stockhub.co/research/Belite_Bio,_Inc’